Synopsis
According to Pharmacy Purchasing & Products’ 2010 State of Pharmacy Compounding survey, a majority (64%) of pharmacy directors outsource some part of their compounding activities to third parties. Furthermore, the study found that 26% plan to increase their use of contract compounders in the future. The effect on pharmacy budgets from the move to increasingly outsource more of the compounded sterile preparation (CSP) workload is driving a simultaneous search for increased efficiencies.
